{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:32:24Z","timestamp":1782203544258,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11046-019-00374-3","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T04:02:57Z","timestamp":1566792177000},"page":"667-670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment Failure of Isavuconazole in a Patient with Cryptococcosis"],"prefix":"10.1007","volume":"184","author":[{"given":"Kathleen A.","family":"Linder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejal N.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-0512","authenticated-orcid":false,"given":"Marisa H.","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"issue":"10","key":"374_CR1","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/cid\/civ571","volume":"61","author":"MH Miceli","year":"2015","unstructured":"Miceli MH, Kauffman CA. Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis. 2015;61(10):1558\u201365.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"374_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/cid\/ciw305","volume":"63","author":"GR Thompson 3rd","year":"2016","unstructured":"Thompson GR 3rd, Rendon A, Dos Santos RR, Queiroz-Telles F, Ostrosky-Zeichner L, Azie N, et al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016;63(3):356\u201362.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"374_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/cpt.620","volume":"101","author":"J Keirns","year":"2017","unstructured":"Keirns J, Desai A, Kowalski D, Lademacher C, Mujais S, Parker B, et al. QT interval shortening with isavuconazole: in vitro and in vivo effects on cardiac repolarization. Clin Pharmacol Ther. 2017;101(6):782\u201390.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"374_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/myc.12731","volume":"61","author":"SC Mellinghoff","year":"2018","unstructured":"Mellinghoff SC, Bassetti M, Dorfel D, Hagel S, Lehners N, Pils A, et al. Isavuconazole shortens the QTc interval. Mycoses. 2018;61(4):256\u201360.","journal-title":"Mycoses"},{"key":"374_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/cid\/ciy260","volume":"67","author":"M Fung","year":"2018","unstructured":"Fung M, Schwatrz BS, Doernberg SB, Langelier C, Lo M, Graff L, et al. Breakthrough invasive fungal infections on isavuconazole prophylaxis and treatment: what is happening in the real-world setting? Clin Infect Dis. 2018;67:1142\u20133.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"374_CR6","first-page":"1610","volume":"67","author":"CR Rausch","year":"2018","unstructured":"Rausch CR, DiPippo AJ, Bose P, Kontoyiannis DP. Breakthrough fungal infections in leukemia patients receiving isavuconazole. Clin Infect Dis. 2018;67(10):1610\u20133.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"374_CR7","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1128\/JCM.01190-13","volume":"51","author":"K Datta","year":"2013","unstructured":"Datta K, Rhee P, Byrnes E 3rd, Garcia-Effron G, Perlin DS, Staab JF, et al. Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility. J Clin Microbiol. 2013;51(9):3090\u20133.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"374_CR8","doi-asserted-by":"publisher","first-page":"e01230-18","DOI":"10.1128\/AAC.01230-18","volume":"62","author":"MA Pfaller","year":"2018","unstructured":"Pfaller MA, Rhomberg PR, Wiederhold NP, Gibas C, Sanders C, Fan H, et al. In vitro activity of isavuconazole against opportunistic pathogens from two mycology reference laboratories. Antimicrob Agent Chemother. 2018;62(10):e01230-18.","journal-title":"Antimicrob Agent Chemother"},{"issue":"1","key":"374_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/AAC.04055-14","volume":"59","author":"A Espinel-Ingroff","year":"2015","unstructured":"Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Guinea J, Hagen F, Meis JF, et al. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans\u2013Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method. Antimicrob Agent Chemother. 2015;59(1):666\u20138.","journal-title":"Antimicrob Agent Chemother"},{"key":"374_CR10","unstructured":"CLSI subcommittee on antifungal susceptibility. Meeting resources, January 2018. Accessed \n                    https:\/\/clsi.org\/meetings\/sub-antifungal\/\n                    \n                   on 14 Mar 2019."},{"key":"374_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","volume":"85","author":"M Castanhiera","year":"2016","unstructured":"Castanhiera M, Messer SA, Rhomberg PR, Pfaller MA. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013). Diagn Microbiol Infect Dis. 2016;85:200\u20134.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"374_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/myc.12847","volume":"62","author":"A Vena","year":"2019","unstructured":"Vena A, Munoz P, Guinea J, Escribano P, Pelaez T, Valerio M, et al. Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis. Mycoses. 2019;62:441\u20139.","journal-title":"Mycoses"},{"key":"374_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ijantimicag.2014.05.015","volume":"44","author":"MN Gamaletsou","year":"2014","unstructured":"Gamaletsou MN, Daikos GL, Walsh TJ, Perlin DS, Ortigosa CJ, Psaroulaki A, et al. Breakthrough candidaemia caused by phenologically susceptible Candida spp in patients with haematological malignancies does not correlate with established interpretive breakpoints. Int J Antimicrob Agent. 2014;44:248\u201355.","journal-title":"Int J Antimicrob Agent"},{"key":"374_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infections Diseases Society of America. Clin Infect Dis. 2016;63:e1\u201360.","journal-title":"Clin Infect Dis"},{"key":"374_CR15","unstructured":"Committee SIFIG. Dutch working party on antibiotic therapy. SWAB guidelines for the management of invasive fungal infections. Revised version. Released: 14 Dec 2017. \n                    http:\/\/www.swab.nl\/swab\/cms3.nsf\/uploads\/3AA7A56CE879587BC12581F80061297F\/$FILE\/SWAB%20Richtlijn%20Mycosen%202017%20(final).pdf\n                    \n                  ."},{"key":"374_CR16","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1093\/ofid\/ofx163.669","volume":"4","author":"P Kim","year":"2017","unstructured":"Kim P, Tegtmeier B, Dadwal S, Ito J, Kriengkauykiat J. Correlating isavuconazole serum levels with efficacy and adverse effects (AE) among immunocompromised patients. Open Forum Infect Dis. 2017;4:S293.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"374_CR17","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1093\/jac\/dkz188","volume":"74","author":"E Furfaro","year":"2019","unstructured":"Furfaro E, Signori A, Di Grazia C, Dominietto A, Raiola AM, Aquino S, Ghiggi C, Ghiso A, Ungaro R, Angellucci E, Viscoli C, Mikulska M. Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy. J Antimicrob Chemother 2019;74(8):2341\u20132346.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"374_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the treatment of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(3):291\u2013322.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"374_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s11046-018-0314-1","volume":"183","author":"JP Bouchara","year":"2018","unstructured":"Bouchara JP, Chaturvedi V. The curious case of \u201ccase report\u201d of infections caused by human and animal fungal pathogens: an educational tool, an online archive, or a format in need of retooling. Mycopathologia. 2018;183(6):879\u201391.","journal-title":"Mycopathologia"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-019-00374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-019-00374-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-019-00374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T02:02:39Z","timestamp":1572573759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-019-00374-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1007\/s11046-019-00374-3","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]},"assertion":[{"value":"27 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors confirm that this material is original and has not been published in whole or in part elsewhere; that the manuscript is not currently being considered for publication in another journal; and that all authors have been personally and actively involved in substantive work leading to the manuscript, and will hold themselves jointly and individually responsible for its content. In addition, the authors confirm that they have completed the checklist for submission of a case report to <i>Mycopathologia<\/i> published by Bouchara et al. [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}}]}}